![](/img/cover-not-exists.png)
A multicenter phase II clinical trial using dacarbazine and continuous infusion lnterleukin-2 for metastatic melanoma. Clinical data and immunomonitoring
Reinhard Dummer, Günter Burg, Martin E. Gore, Barry W. Hancock, Pierre J. Guillou, Heleen C. Grobben, Ralph Oskam, Jeanne P. Dieleman, Jürgen C. BeckerVolume:
75
Year:
1995
Language:
english
Pages:
7
DOI:
10.1002/1097-0142(19950215)75:43.0.co;2-f
File:
PDF, 563 KB
english, 1995